BACKGROUND: Shortening of chromosomal telomeres is a consequence of cell division and is a biological factor related to cellular aging and potentially to more rapid organismal biological aging. OBJECTIVE: To determine whether shorter telomere length (TL), as measured in human blood samples, is associated with the development of Alzheimer disease and mortality. DESIGN: We studied available stored leukocyte DNA from a community-based study of aging using realtime polymerase chain reaction analysis to determine mean TL in our modification of a method measuring the ratio of telomere sequence to single-copy gene sequence. SETTING: A multiethnic community-based study of aging and dementia. PARTICIPANTS: One thousand nine hundred eighty-three subjects 65 years or older. Mean (SD) age at blood draw was 78.3 (6.9) years; at death, 86.0 (7.4) years. Median follow-up for mortality was 9.3 years; 190 (9.6%) developed incident dementia. RESULTS: The TL was inversely related to age and shorter in men than women. Persons dying during follow-up had a shorter TL compared with survivors (mean [SD], 6218 [819] vs 6491 [881] base pairs [bp] [P.001]), even after adjustment for age, sex, education, and apolipoprotein E genotype. Individuals who developed dementia had significantly shorter TL (mean [SD], 6131 [798] bp for prevalent cases and 6315 [817] bp for incident cases) compared with those remaining dementia-free (6431 [864] bp). Cox-regression analyses showed that shorter TL was a risk for earlier onset of dementia (P=.05), but stratified analyses for sex showed that this association of age at onset of dementia with shorter TL was significant in women only. CONCLUSION: Our findings suggest that shortened leukocyte TL is associated with risks for dementia and mortality and may therefore be a marker of biological aging.
BACKGROUND: Shortening of chromosomal telomeres is a consequence of cell division and is a biological factor related to cellular aging and potentially to more rapid organismal biological aging. OBJECTIVE: To determine whether shorter telomere length (TL), as measured in human blood samples, is associated with the development of Alzheimer disease and mortality. DESIGN: We studied available stored leukocyte DNA from a community-based study of aging using realtime polymerase chain reaction analysis to determine mean TL in our modification of a method measuring the ratio of telomere sequence to single-copy gene sequence. SETTING: A multiethnic community-based study of aging and dementia. PARTICIPANTS: One thousand nine hundred eighty-three subjects 65 years or older. Mean (SD) age at blood draw was 78.3 (6.9) years; at death, 86.0 (7.4) years. Median follow-up for mortality was 9.3 years; 190 (9.6%) developed incident dementia. RESULTS: The TL was inversely related to age and shorter in men than women. Persons dying during follow-up had a shorter TL compared with survivors (mean [SD], 6218 [819] vs 6491 [881] base pairs [bp] [P.001]), even after adjustment for age, sex, education, and apolipoprotein E genotype. Individuals who developed dementia had significantly shorter TL (mean [SD], 6131 [798] bp for prevalent cases and 6315 [817] bp for incident cases) compared with those remaining dementia-free (6431 [864] bp). Cox-regression analyses showed that shorter TL was a risk for earlier onset of dementia (P=.05), but stratified analyses for sex showed that this association of age at onset of dementia with shorter TL was significant in women only. CONCLUSION: Our findings suggest that shortened leukocyte TL is associated with risks for dementia and mortality and may therefore be a marker of biological aging.
Authors: L A Panossian; V R Porter; H F Valenzuela; X Zhu; Erin Reback; D Masterman; J L Cummings; R B Effros Journal: Neurobiol Aging Date: 2003 Jan-Feb Impact factor: 4.673
Authors: G Maestre; R Ottman; Y Stern; B Gurland; M Chun; M X Tang; M Shelanski; B Tycko; R Mayeux Journal: Ann Neurol Date: 1995-02 Impact factor: 10.422
Authors: Lawrence S Honig; Ming-Xin Tang; Steven Albert; Rosanne Costa; Jose Luchsinger; Jennifer Manly; Yaakov Stern; Richard Mayeux Journal: Arch Neurol Date: 2003-12
Authors: Devin Wahl; Victoria C Cogger; Samantha M Solon-Biet; Rosilene V R Waern; Rahul Gokarn; Tamara Pulpitel; Rafael de Cabo; Mark P Mattson; David Raubenheimer; Stephen J Simpson; David G Le Couteur Journal: Ageing Res Rev Date: 2016-06-26 Impact factor: 10.895
Authors: Rosebud O Roberts; Lisa A Boardman; Ruth H Cha; V Shane Pankratz; Ruth A Johnson; Brooke R Druliner; Teresa J H Christianson; Lewis R Roberts; Ronald C Petersen Journal: Mech Ageing Dev Date: 2014-10-22 Impact factor: 5.432
Authors: Kyle Lapham; Mark N Kvale; Jue Lin; Sheryl Connell; Lisa A Croen; Brad P Dispensa; Lynn Fang; Stephanie Hesselson; Thomas J Hoffmann; Carlos Iribarren; Eric Jorgenson; Lawrence H Kushi; Dana Ludwig; Tetsuya Matsuguchi; William B McGuire; Sunita Miles; Charles P Quesenberry; Sarah Rowell; Marianne Sadler; Lori C Sakoda; David Smethurst; Carol P Somkin; Stephen K Van Den Eeden; Lawrence Walter; Rachel A Whitmer; Pui-Yan Kwok; Neil Risch; Catherine Schaefer; Elizabeth H Blackburn Journal: Genetics Date: 2015-06-19 Impact factor: 4.562
Authors: Yian Gu; Lawrence S Honig; Nicole Schupf; Joseph H Lee; Jose A Luchsinger; Yaakov Stern; Nikolaos Scarmeas Journal: Age (Dordr) Date: 2015-03-08
Authors: Belinda L Needham; David Rehkopf; Nancy Adler; Steven Gregorich; Jue Lin; Elizabeth H Blackburn; Elissa S Epel Journal: Epidemiology Date: 2015-07 Impact factor: 4.822
Authors: Jennifer A Doherty; Laurie Grieshober; John R Houck; Matthew J Barnett; Jean De Dieu Tapsoba; Mark Thornquist; Ching-Yun Wang; Gary E Goodman; Chu Chen Journal: Cancer Epidemiol Biomarkers Prev Date: 2018-05-09 Impact factor: 4.254
Authors: Kevin S King; Julia Kozlitina; Roger N Rosenberg; Ronald M Peshock; Roderick W McColl; Christine K Garcia Journal: JAMA Neurol Date: 2014-10 Impact factor: 18.302